i-Sens to acquire AgaMatrix for $27m.

Financials

Edit Data

Transaction Value£21m

Consideration TypeCash

Capital Owned-

Capital Bid For100%

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

AGAMATRIX

bidder

I-SENS

Sources

Edit

Tags

Edit

glucose monitoring devices

Acquisition

Friendly

Single Bidder

Cross Border

Majority

Pending

Private

Medical Equipment

United States

Synopsis

Edit

i-Sens, a South Korean maker of diabetes-related devices, agreed to acquire AgaMatrix, an American manufacturer of blood glucose monitoring devices, for $27m.

i-Sens to acquire AgaMatrix for $27m.

target

bidder

legal advisors